Clinical ResearchSequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat
Under an Elsevier user license
open archive
Central Illustration
Key Words
heart failure
natriuretic peptide
N-terminal pro-B-type natriuretic peptide (NT-proBNP)
vericiguat
Abbreviations and Acronyms
HF
heart failure
HFrEF
heart failure with reduced ejection fraction
NT-proBNP
N-terminal pro–B-type natriuretic peptide
OR
odds ratio
SGLT2
sodium-glucose cotransporter-2
Cited by (0)
John Teerlink, MD, served as the Guest Editor for this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2022 by the American College of Cardiology Foundation. Published by Elsevier.